Crispr Therapeutics shares owned by Carnegie Capital Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Carnegie Capital Asset Management
from 13F filings
Historical chart of Carnegie Capital Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Carnegie Capital Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Carnegie Capital Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $4.6M | 74k | 62.60 |
| 2023-09-30 | $4.0M | 89k | 45.39 |
| 2023-06-30 | $3.4M | 61k | 56.14 |
| 2022-12-31 | $1.0M | 26k | 40.65 |
| 2022-09-30 | $3.8M | 58k | 65.35 |
| 2022-06-30 | $19M | 117k | 161.89 |
| 2022-03-31 | $5.4M | 86k | 62.76 |
| 2021-12-31 | $9.0M | 118k | 75.78 |
| 2021-09-30 | $13M | 119k | 111.93 |
| 2021-06-30 | $19M | 117k | 161.89 |
| 2021-03-31 | $13M | 110k | 121.85 |
| 2020-12-31 | $14M | 94k | 153.11 |
| 2020-09-30 | $7.5M | 89k | 83.64 |
| 2020-06-30 | $6.7M | 92k | 73.50 |
| 2020-03-31 | $2.8M | 66k | 42.41 |
| 2019-12-31 | $2.3M | 38k | 60.91 |
| 2019-09-30 | $1.0M | 25k | 41.00 |
| 2019-06-30 | $1.1M | 23k | 47.08 |
More positions owned by Carnegie Capital Asset Management
View all positions for Carnegie Capital Asset Management